Clinical Trial Update: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

View source ↗

Summary

Clinical trial evaluating a biological therapy's effect on biomarkers in untreated Hepatitis C, metastatic melanoma, and Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Hepatitis C
• Melanoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Melanoma | Status: TERMINATED